172 related articles for article (PubMed ID: 29437791)
21. Safety of pioglitazone during and after radiation therapy in patients with brain tumors: a phase I clinical trial.
Cramer CK; Alphonse-Sullivan N; Isom S; Metheny-Barlow LJ; Cummings TL; Page BR; Brown DR; Blackstock AW; Peiffer AM; Strowd RE; Rapp S; Lesser GJ; Shaw EG; Chan MD
J Cancer Res Clin Oncol; 2019 Feb; 145(2):337-344. PubMed ID: 30417218
[TBL] [Abstract][Full Text] [Related]
22.
Bayne RS; Puckett S; Rodrigues LU; Cramer SD; Lee J; Furdui CM; Chou JW; Miller LD; Ornelles DA; Lyles DS
Mol Ther Oncolytics; 2020 Jun; 17():496-507. PubMed ID: 32529027
[TBL] [Abstract][Full Text] [Related]
23. Loss of XIST in Breast Cancer Activates MSN-c-Met and Reprograms Microglia via Exosomal miRNA to Promote Brain Metastasis.
Xing F; Liu Y; Wu SY; Wu K; Sharma S; Mo YY; Feng J; Sanders S; Jin G; Singh R; Vidi PA; Tyagi A; Chan MD; Ruiz J; Debinski W; Pasche BC; Lo HW; Metheny-Barlow LJ; D'Agostino RB; Watabe K
Cancer Res; 2018 Aug; 78(15):4316-4330. PubMed ID: 30026327
[TBL] [Abstract][Full Text] [Related]
24. Mitochondrial Metabolism as a Target for Cancer Therapy.
Vasan K; Werner M; Chandel NS
Cell Metab; 2020 Sep; 32(3):341-352. PubMed ID: 32668195
[TBL] [Abstract][Full Text] [Related]
25. Targeting mitochondrial respiration for the treatment of acute myeloid leukemia.
Carter JL; Hege K; Kalpage HA; Edwards H; Hüttemann M; Taub JW; Ge Y
Biochem Pharmacol; 2020 Dec; 182():114253. PubMed ID: 33011159
[TBL] [Abstract][Full Text] [Related]
26. Targeting Myeloperoxidase Disrupts Mitochondrial Redox Balance and Overcomes Cytarabine Resistance in Human Acute Myeloid Leukemia.
Hosseini M; Rezvani HR; Aroua N; Bosc C; Farge T; Saland E; Guyonnet-Dupérat V; Zaghdoudi S; Jarrou L; Larrue C; Sabatier M; Mouchel PL; Gotanègre M; Piechaczyk M; Bossis G; Récher C; Sarry JE
Cancer Res; 2019 Oct; 79(20):5191-5203. PubMed ID: 31358527
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial ClpP-Mediated Proteolysis Induces Selective Cancer Cell Lethality.
Ishizawa J; Zarabi SF; Davis RE; Halgas O; Nii T; Jitkova Y; Zhao R; St-Germain J; Heese LE; Egan G; Ruvolo VR; Barghout SH; Nishida Y; Hurren R; Ma W; Gronda M; Link T; Wong K; Mabanglo M; Kojima K; Borthakur G; MacLean N; Ma MCJ; Leber AB; Minden MD; Houry W; Kantarjian H; Stogniew M; Raught B; Pai EF; Schimmer AD; Andreeff M
Cancer Cell; 2019 May; 35(5):721-737.e9. PubMed ID: 31056398
[TBL] [Abstract][Full Text] [Related]
28. Targeting Mitochondrial Structure Sensitizes Acute Myeloid Leukemia to Venetoclax Treatment.
Chen X; Glytsou C; Zhou H; Narang S; Reyna DE; Lopez A; Sakellaropoulos T; Gong Y; Kloetgen A; Yap YS; Wang E; Gavathiotis E; Tsirigos A; Tibes R; Aifantis I
Cancer Discov; 2019 Jul; 9(7):890-909. PubMed ID: 31048321
[TBL] [Abstract][Full Text] [Related]
29. Targeting Altered Energy Metabolism in Colorectal Cancer: Oncogenic Reprogramming, the Central Role of the TCA Cycle and Therapeutic Opportunities.
Neitzel C; Demuth P; Wittmann S; Fahrer J
Cancers (Basel); 2020 Jun; 12(7):. PubMed ID: 32610612
[TBL] [Abstract][Full Text] [Related]
30. Tumor cells dictate anti-tumor immune responses by altering pyruvate utilization and succinate signaling in CD8
Elia I; Rowe JH; Johnson S; Joshi S; Notarangelo G; Kurmi K; Weiss S; Freeman GJ; Sharpe AH; Haigis MC
Cell Metab; 2022 Aug; 34(8):1137-1150.e6. PubMed ID: 35820416
[TBL] [Abstract][Full Text] [Related]
31. Increased demand for NAD
Luengo A; Li Z; Gui DY; Sullivan LB; Zagorulya M; Do BT; Ferreira R; Naamati A; Ali A; Lewis CA; Thomas CJ; Spranger S; Matheson NJ; Vander Heiden MG
Mol Cell; 2021 Feb; 81(4):691-707.e6. PubMed ID: 33382985
[TBL] [Abstract][Full Text] [Related]
32. Lactate Limits T Cell Proliferation via the NAD(H) Redox State.
Quinn WJ; Jiao J; TeSlaa T; Stadanlick J; Wang Z; Wang L; Akimova T; Angelin A; Schäfer PM; Cully MD; Perry C; Kopinski PK; Guo L; Blair IA; Ghanem LR; Leibowitz MS; Hancock WW; Moon EK; Levine MH; Eruslanov EB; Wallace DC; Baur JA; Beier UH
Cell Rep; 2020 Dec; 33(11):108500. PubMed ID: 33326785
[TBL] [Abstract][Full Text] [Related]
33. Obesity Shapes Metabolism in the Tumor Microenvironment to Suppress Anti-Tumor Immunity.
Ringel AE; Drijvers JM; Baker GJ; Catozzi A; García-Cañaveras JC; Gassaway BM; Miller BC; Juneja VR; Nguyen TH; Joshi S; Yao CH; Yoon H; Sage PT; LaFleur MW; Trombley JD; Jacobson CA; Maliga Z; Gygi SP; Sorger PK; Rabinowitz JD; Sharpe AH; Haigis MC
Cell; 2020 Dec; 183(7):1848-1866.e26. PubMed ID: 33301708
[TBL] [Abstract][Full Text] [Related]
34. pH-Gated Succinate Secretion Regulates Muscle Remodeling in Response to Exercise.
Reddy A; Bozi LHM; Yaghi OK; Mills EL; Xiao H; Nicholson HE; Paschini M; Paulo JA; Garrity R; Laznik-Bogoslavski D; Ferreira JCB; Carl CS; Sjøberg KA; Wojtaszewski JFP; Jeppesen JF; Kiens B; Gygi SP; Richter EA; Mathis D; Chouchani ET
Cell; 2020 Oct; 183(1):62-75.e17. PubMed ID: 32946811
[TBL] [Abstract][Full Text] [Related]
35. SUCNR1 controls an anti-inflammatory program in macrophages to regulate the metabolic response to obesity.
Keiran N; Ceperuelo-Mallafré V; Calvo E; Hernández-Alvarez MI; Ejarque M; Núñez-Roa C; Horrillo D; Maymó-Masip E; Rodríguez MM; Fradera R; de la Rosa JV; Jorba R; Megia A; Zorzano A; Medina-Gómez G; Serena C; Castrillo A; Vendrell J; Fernández-Veledo S
Nat Immunol; 2019 May; 20(5):581-592. PubMed ID: 30962591
[TBL] [Abstract][Full Text] [Related]
36. Distinct Regulation of Th17 and Th1 Cell Differentiation by Glutaminase-Dependent Metabolism.
Johnson MO; Wolf MM; Madden MZ; Andrejeva G; Sugiura A; Contreras DC; Maseda D; Liberti MV; Paz K; Kishton RJ; Johnson ME; de Cubas AA; Wu P; Li G; Zhang Y; Newcomb DC; Wells AD; Restifo NP; Rathmell WK; Locasale JW; Davila ML; Blazar BR; Rathmell JC
Cell; 2018 Dec; 175(7):1780-1795.e19. PubMed ID: 30392958
[TBL] [Abstract][Full Text] [Related]
37. A novel differentiation response with combination IDH inhibitor and intensive induction therapy for AML.
Mason EF; Pozdnyakova O; Roshal M; Fathi AT; Stein EM; Ferrell PB; Shaver AC; Frattini M; Wang H; Hua L; Mu J; Choe S; Xu R; Almon C; Cooper M; Stone RM; Hasserjian RP; Savona MR
Blood Adv; 2021 Apr; 5(8):2279-2283. PubMed ID: 33904894
[No Abstract] [Full Text] [Related]
38. PGC1A driven enhanced mitochondrial DNA copy number predicts outcome in pediatric acute myeloid leukemia.
Chaudhary S; Ganguly S; Palanichamy JK; Singh A; Bakhshi R; Jain A; Chopra A; Bakhshi S
Mitochondrion; 2021 May; 58():246-254. PubMed ID: 33812061
[TBL] [Abstract][Full Text] [Related]
39. VISTA: A Mediator of Quiescence and a Promising Target in Cancer Immunotherapy.
Yuan L; Tatineni J; Mahoney KM; Freeman GJ
Trends Immunol; 2021 Mar; 42(3):209-227. PubMed ID: 33495077
[TBL] [Abstract][Full Text] [Related]
40. Metabolites and the tumour microenvironment: from cellular mechanisms to systemic metabolism.
Elia I; Haigis MC
Nat Metab; 2021 Jan; 3(1):21-32. PubMed ID: 33398194
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
